Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

达菲林 - NMPA Drug Approval Details

Approvals/NMPA/Triptorelin Acetate for Injection

Approved

化学药品

Triptorelin Acetate for Injection

IPSEN PHARMA🇨🇳 National Medical Products Administration

Approval Date: Jun 7, 2023
Approval ID: 8TELntvIMnG
Company: IPSEN PHARMA
Type: 化学药品

Approval Details

Approval Id: 8TELntvIMnG
Approval Number: 国药准字HJ20140298
Generic Name: 注射用醋酸曲普瑞林
Generic Name En: Triptorelin Acetate for Injection
Trade Name: 达菲林
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 3.75mg（以C₆₄H₈₂N₁₈O₁₃计）
Reg Date: 2023-06-07
Expired Date: 2028-06-06
Company Name: IPSEN PHARMA
Production Company Name: IPSEN PHARMA BIOTECH
Company Detail Path: /organization/ipsen-pharma
Production Company Detail Path: /organization/ipsen-pharma-biotech

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 7, 2023

Approval ID

8TELntvIMnG

Type

化学药品

Back to NMPA Approvals